(NP (NP Single/JJ point/NN estimation/NN) (PP of/IN (NP (NP glucocorticoid/NN receptors/NNS) (PP in/IN (NP (NP lymphocytes/NNS) (PP-COOD (PP of/IN (NP normal/JJ subjects/NNS)) and/CC (PP of/IN (NP (NP children/NNS) (PP under/IN (NP long/JJ term/NN glucocorticoid/NN treatment/NN))))))))) ./.)
(S (NP-SBJ-45 (NP A/DT single/JJ point/NN assay/NN) (PP of/IN (NP (NP (NP glucocorticoid/NN receptors/NNS) (PRN -LRB-/-LRB- (NP GR/NN) -RRB-/-RRB-)) (PP in/IN (NP human/JJ lymphocytes/NNS)))) (PP based/VBN (PP on/IN (NP (NP the/DT measurement/NN) (PP of/IN (NP specific/JJ dexamethasone/NN binding/NN)))))) (VP has/VBZ (VP been/VBN (VP-COOD (VP developed/VBN (NP *-45/-NONE-)) and/CC (VP compared/VBN (NP *-45/-NONE-) (PP with/IN (NP a/DT common/JJ multi-point/JJ Scatchard/NN analysis/NN)))))) ./.)
(S (NP-SBJ-47 (NP The/DT assay/NN conditions/NN) -/: (NP-COOD (NP (NP concentration/NN (PP of/IN (NP the/DT ligand/NN))) (NP 20/CD nmol\/l/NN)) ,/, (NP incubation/NN time/NN 2/CD h/NN) and/CC (NP (NP the/DT cell/NN count/NN (QP 2-6/CD) mil./CD cells\/tube/NNS) (PP in/IN (NP the/DT assay/NN volume/NN 0.25/CD ml/NN))))) (VP were/VBD (VP found/VBN (S (NP-SBJ *-47/-NONE-) (VP to/TO (VP be/VB (ADJP-PRD optimal/JJ)))))) ./.)
(S (NP-SBJ-46 An/DT attempt/NN (S *ICH*-48/-NONE-)) (VP was/VBD (ADVP also/RB) (VP undertaken/VBN (NP *-46/-NONE-) (S-48 (NP-SBJ */-NONE-) (VP to/TO (VP use/VB (NP a/DT cell/NN harvester/NN) (PP for/IN (NP (NP the/DT separation/NN) (PP of/IN (NP cells/NNS)) (PP from/IN (NP unbound/JJ ligand/NN))))))))) ./.)
(S (SBAR-ADV Though/IN (S (NP-SBJ-COOD (NP (NP (ADJP specifically/RB bound/VBN) dexamethasone/NN) (VP measured/VBN (NP */-NONE-) (PP by/IN (NP whole-cell/JJ assay/NN)))) and/CC (NP (NP that/DT) (VP using/VBG (NP cell/NN harvester/NN)))) (VP correlated/VBD (ADVP well/RB)))) ,/, (NP-SBJ (NP (ADJP (PP almost/RB by/IN (NP one/CD order/NN)) lower/JJR) values/NNS) (VP obtained/VBN (NP */-NONE-) (PP with/IN (NP the/DT latter/JJ method/NN)))) (VP render/VBP (S (NP-SBJ it/PRP) (ADJP-PRD non-applicable/JJ (PP for/IN (NP receptor/NN quantitation/NN))))) ./.)
(S (NP-SBJ (NP (NP The/DT results/NNS) (PP from/IN (NP 9/CD healthy/JJ volunteers/NNS))) (PRN -LRB-/-LRB- (FRAG (NP average/JJ GR/NN concentration/NN (NP (QP 7131/CD +\/-/CC 1256/CD) sites\/cell/NNS))) -RRB-/-RRB-)) (VP correlated/VBD (ADVP excellently/RB) (PP with/IN (NP (NP those/DT) (VP obtained/VBN (NP */-NONE-) (PP by/IN (NP the/DT Scatchard/NN analysis/NN)))))) ./.)
(S (NP-SBJ-49 The/DT single/JJ point/NN assay/NN) (VP has/VBZ (VP been/VBN (ADVP also/RB) (VP applied/VBN (NP *-49/-NONE-) (PP for/IN (NP (NP determination/NN) (PP of/IN (NP (NP GH/NN) (PP in/IN (NP (NP 10/CD children/NNS) (VP treated/VBN (NP */-NONE-) (PP with/IN (NP (NP large/JJ doses/NNS) (PP of/IN (NP prednisone/NN)))))))))))))) ./.)
(S (NP-SBJ (NP The/DT average/JJ values/NNS) (PP from/IN (NP healthy/JJ volunteers/NNS))) (VP did/VBD not/RB (VP differ/VB (ADVP significantly/RB) (PP from/IN (NP (NP those/DT) (VP found/VBN (NP */-NONE-) (PP in/IN (NP these/DT children/NNS))))) ,/, (SBAR though/RB (S (NP-SBJ-50 (ADJP much/RB broader/JJR) range/NN) (VP was/VBD (VP found/VBN (NP *-50/-NONE-) (PP in/IN (NP patients/NNS)))))))) ./.)
